4
Changes in Ownership
Bausch Health Companies Inc. Filed Acc 0001127602-22-008251
U.S. President-Pharma Business sold 1,595 shares at $23.37 ($37,275)
- U.S. President-Pharma Business acquired 35,627 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Spurr Robert U.S. President-Pharma Business | 2022-03-02 | Sale | −1,595 | $23.37 | $37,275 | 65,394 | D |
| Spurr Robert U.S. President-Pharma Business | 2022-03-02 | Grant or award | +35,627 | $24.17 | $861,105 | 101,021 | D |
| Derivatives | |||||||
| Spurr Robert U.S. President-Pharma Business | 2022-03-02 | Grant or award · Non-Qualified Stock Options (right to purchase) | +131,910 | 131,910 | D | ||
| Open-market sales · 1,595 sh · avg $23.37 · $37,275 | |||||||
Loading xslF345X03/form4.xml…